Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions

por Bedrose, Sara, Daher, Marilyne, Altameemi, Lina, Habra, Mouhammed Amir
Publicado 2020

1891. Repeated Assessment of SARS-CoV-2 Seroprevalence among Health Care Workers Early in the Pandemic: Relationship to Workplace Exposures

por Demian, Sherry, Awuah, Dominic O, Osterholzer, Danielle, Altameemi, Lina, Rios-Bedoya, Carlos, Taftaf, Ahmad, Nguyen, Hoang C
Publicado 2022

SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma

por Bedrose, Sara Shokry Daniel, Altameemi, Lina, Daher, Marilyne, De Rosa, Gina Tamsen, Varghese, Jeena Mary, Jimenez, Camilo, Campbell, Matthew, Habra, Mouhammed Amir
Publicado 2020

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

por Awiwi, Muhammad O, Elsayes, Khaled M, Mohamed, Yehia I, Altameemi, Lina, Gjoni, Migena, Irshad, Omayr Muhammad, Sayed Ahmed, Ahmed, Kaseb, Ahmad O, Salem, Usama
Publicado 2022

The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection

por Kaseb, Ahmed O., Mohamed, Yehia I., Malek, Alexandre E., Raad, Issam I., Altameemi, Lina, Li, Dan, Kaseb, Omar A., Kaseb, Safa A., Selim, Abdelhafez, Ma, Qing
Publicado 2021

MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center

por Fazeli, Sasan, Dadu, Ramona, Waguespack, Steven G, Sherman, Steven I, Busaidy, Naifa Lamki, Hu, Mimi I, Jimenez, Camilo, Habra, Mouhammed A, Williams, Michelle, Altameemi, Lina, Poropatich, Kate, Routbort, Mark J, Luthra, Raja, Patel, Keyur P, Cabanillas, Maria
Publicado 2020

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

por Bedrose, Sara, Miller, Kevin Charles, Altameemi, Lina, Ali, Mohamed S, Nassar, Sameh, Garg, Naveen, Daher, Marilyne, Eaton, Keith D, Yorio, Jeffrey Thomas, Daniel, Davey B, Campbell, Matthew, Bible, Keith C, Ryder, Mabel, Chintakuntlawar, Ashish V, Habra, Mouhammed Amir
Publicado 2020

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

por Mohamed, Yehia I., Duda, Dan G., Awiwi, Muhammad O., Lee, Sunyoung S., Altameemi, Lina, Xiao, Lianchun, Morris, Jeffrey S., Wolff, Robert A., Elsayes, Khaled M., Hatia, Rikita I., Qayyum, Aliya, Chamseddine, Shadi M., Rashid, Asif, Yao, James C., Mahvash, Armeen, Hassan, Manal M., Amin, Hesham M., Kaseb, Ahmed Omar
Publicado 2022